Literature DB >> 16971010

An "in silico" clinical trial comparing free breathing, slow and respiration correlated computed tomography in lung cancer patients.

Geert Bosmans1, Jeroen Buijsen, André Dekker, Marije Velders, Liesbeth Boersma, Dirk De Ruysscher, André Minken, Philippe Lambin.   

Abstract

BACKGROUND AND
PURPOSE: To determine which method of internal target volume (ITV) definition based on a respiration correlated CT (RCCT) allows optimal tumor coverage.
MATERIAL AND METHODS: A free breathing CT (CT(fb)) and an RCCT scan were acquired in 41 lung cancer patients. For 12 patients with a motion >7 mm in any direction, a detailed analysis was made. The RCCT scan was used to measure tumor motion and to reconstruct a CT at 10 phases (CT(10ph)), amongst which the half ventilation CT (CT(hv)). By averaging the CT(10ph), a slow CT (CT(slow)) was reconstructed. Based on those scans ITVs were delineated and treatments were planned, where for the ITV(hv) an internal margin of (motion amplitude)/4 was used. The treatment plans for the ITVs were projected on the 10 respiration phases. Doses were calculated and averaged over the 10 phases to estimate the actual CTV coverage.
RESULTS: The 3D motion was on average 8.1+/-1.0 mm (1 SD) for all patients; no statistical difference was found between lower and upper lobe tumors. The ITV(slow) was the smallest volume on average (142+/-38 cm(3)), followed by the ITV(hv) (160+/-40 cm(3)), the ITV(10ph) (161+/-41 cm(3)) and the ITV(fb) (250+/-63 cm(3)). Mean CTV doses were between 95% and 107% of the prescribed dose for nearly all patients and treatment plans. Analysis of the CTV coverage suggested that underdosage may occur when the CT(slow) is used and a geographic miss occurred using the CT(fb), due to uncorrect localization of the average tumor position.
CONCLUSIONS: The CT(hv) seems to be the optimal dataset for delineation, using an adequate anisotropic internal margin of (motion amplitude)/4.

Entities:  

Mesh:

Year:  2006        PMID: 16971010     DOI: 10.1016/j.radonc.2006.08.009

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN: 0167-8140            Impact factor:   6.280


  3 in total

1.  Benefits of a clinical data warehouse with data mining tools to collect data for a radiotherapy trial.

Authors:  Erik Roelofs; Lucas Persoon; Sebastiaan Nijsten; Wolfgang Wiessler; André Dekker; Philippe Lambin
Journal:  Radiother Oncol       Date:  2013-02-05       Impact factor: 6.280

2.  Towards a Clinical Decision Support System for External Beam Radiation Oncology Prostate Cancer Patients: Proton vs. Photon Radiotherapy? A Radiobiological Study of Robustness and Stability.

Authors:  Seán Walsh; Erik Roelofs; Peter Kuess; Yvonka van Wijk; Ben Vanneste; Andre Dekker; Philippe Lambin; Bleddyn Jones; Dietmar Georg; Frank Verhaegen
Journal:  Cancers (Basel)       Date:  2018-02-18       Impact factor: 6.639

3.  Recommendations for implementing stereotactic radiotherapy in peripheral stage IA non-small cell lung cancer: report from the Quality Assurance Working Party of the randomised phase III ROSEL study.

Authors:  Coen W Hurkmans; Johan P Cuijpers; Frank J Lagerwaard; Joachim Widder; Uulke A van der Heide; Danny Schuring; Suresh Senan
Journal:  Radiat Oncol       Date:  2009-01-12       Impact factor: 3.481

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.